Article thumbnail

Hypernatremia in a patient treated with sodium polystyrene sulfonate

By Manish Nepal, Ion Dan Bucaloiu and Evan R Norfolk


Severe hyperkalemia requires urgent medical attention and correction in order to prevent arrhythmic complications. Sodium polystyrene sulfonate (SPS) is a cation exchange resin commonly used in the management of hyperkalemia. A recent review raised concerns regarding its effectiveness and potential adverse effects. Hypernatremia in adults in the setting of sodium polystyrene sulfonate therapy has not been described in the literature. We report the case of a woman who developed hypernatremia in the setting of excessive SPS administration and hope to increase awareness among clinicians regarding this potential side effect of SPS therapy

Topics: Case Report
Publisher: Dove Medical Press
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2004). Hypernatraemia induced by sodium polystyrene sulphonate (Kayexalate) in two extremely low birth weight newborns. Paediatr Anaesth.
  2. Ion-exchange resins for treatment of hyperkalemia: are they safe and effective?
  3. Necrosis of the gastrointestinal tract in uremic patients as a result of sodium polystyrene sulfonate (Kayexalate) in sorbitol: an underrecognized condition.
  4. Reduction of serum calcium by sodium sulfonated polystyrene resin.
  5. Treatment of hyponatremia.
  6. Treatment of the oliguric patient with a new sodium-exchange resin and sorbitol.